Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H29N3O2 |
Molecular Weight | 319.4418 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
InChI
InChIKey=SVCQBXMFONNZHX-UHFFFAOYSA-N
InChI=1S/C18H29N3O2/c1-2-19-18(22)20-10-7-13-23-17-9-6-8-16(14-17)15-21-11-4-3-5-12-21/h6,8-9,14H,2-5,7,10-13,15H2,1H3,(H2,19,20,22)
Molecular Formula | C18H29N3O2 |
Molecular Weight | 319.4418 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/8096132Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/8096133,
http://www.ncbi.nlm.nih.gov/pubmed/8096134
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8096132
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/8096133,
http://www.ncbi.nlm.nih.gov/pubmed/8096134
Dalcotidine is a histamine H2 receptor antagonist that demonstrated potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers. Dalcotidine was discontinued in phase III of clinical trials in Japan.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P25021 Gene ID: 3274.0 Gene Symbol: HRH2 Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/8096132 |
0.04 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8096134
Curator's Comment: No human-related information is found.
In rats: 10-50 mg/kg x 2/day
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:34:19 GMT 2023
by
admin
on
Fri Dec 15 16:34:19 GMT 2023
|
Record UNII |
9968S2UKFJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29702
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9968S2UKFJ
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL311206
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
DTXSID4048806
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
SUB06890MIG
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
129319
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
120958-90-9
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
100000084014
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
7571
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY | |||
|
C73218
Created by
admin on Fri Dec 15 16:34:19 GMT 2023 , Edited by admin on Fri Dec 15 16:34:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|